JP2008537546A5 - - Google Patents

Download PDF

Info

Publication number
JP2008537546A5
JP2008537546A5 JP2008502334A JP2008502334A JP2008537546A5 JP 2008537546 A5 JP2008537546 A5 JP 2008537546A5 JP 2008502334 A JP2008502334 A JP 2008502334A JP 2008502334 A JP2008502334 A JP 2008502334A JP 2008537546 A5 JP2008537546 A5 JP 2008537546A5
Authority
JP
Japan
Prior art keywords
nucleic acid
tumor
associated antigen
antibody
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008502334A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008537546A (ja
JP5253999B2 (ja
Filing date
Publication date
Priority claimed from DE102005013846A external-priority patent/DE102005013846A1/de
Application filed filed Critical
Publication of JP2008537546A publication Critical patent/JP2008537546A/ja
Publication of JP2008537546A5 publication Critical patent/JP2008537546A5/ja
Application granted granted Critical
Publication of JP5253999B2 publication Critical patent/JP5253999B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2008502334A 2005-03-24 2006-03-23 腫瘍診断と治療のための表面関連抗原の同定 Expired - Lifetime JP5253999B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005013846A DE102005013846A1 (de) 2005-03-24 2005-03-24 Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
DE102005013846.2 2005-03-24
PCT/EP2006/002695 WO2006100089A2 (de) 2005-03-24 2006-03-23 Identifizierung von oberflächen-assoziierten antigenen für die tumordiagnose und -therapie

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2012083549A Division JP5731436B2 (ja) 2005-03-24 2012-04-02 腫瘍診断と治療のための表面関連抗原の同定
JP2012258431A Division JP5779167B2 (ja) 2005-03-24 2012-11-27 腫瘍診断と治療のための表面関連抗原の同定

Publications (3)

Publication Number Publication Date
JP2008537546A JP2008537546A (ja) 2008-09-18
JP2008537546A5 true JP2008537546A5 (https=) 2009-04-30
JP5253999B2 JP5253999B2 (ja) 2013-07-31

Family

ID=36613498

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2008502334A Expired - Lifetime JP5253999B2 (ja) 2005-03-24 2006-03-23 腫瘍診断と治療のための表面関連抗原の同定
JP2012083549A Expired - Lifetime JP5731436B2 (ja) 2005-03-24 2012-04-02 腫瘍診断と治療のための表面関連抗原の同定
JP2012258431A Expired - Lifetime JP5779167B2 (ja) 2005-03-24 2012-11-27 腫瘍診断と治療のための表面関連抗原の同定
JP2014005640A Expired - Lifetime JP5922159B2 (ja) 2005-03-24 2014-01-16 腫瘍診断と治療のための表面関連抗原の同定
JP2016032631A Expired - Lifetime JP6174177B2 (ja) 2005-03-24 2016-02-24 腫瘍診断と治療のための表面関連抗原の同定

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2012083549A Expired - Lifetime JP5731436B2 (ja) 2005-03-24 2012-04-02 腫瘍診断と治療のための表面関連抗原の同定
JP2012258431A Expired - Lifetime JP5779167B2 (ja) 2005-03-24 2012-11-27 腫瘍診断と治療のための表面関連抗原の同定
JP2014005640A Expired - Lifetime JP5922159B2 (ja) 2005-03-24 2014-01-16 腫瘍診断と治療のための表面関連抗原の同定
JP2016032631A Expired - Lifetime JP6174177B2 (ja) 2005-03-24 2016-02-24 腫瘍診断と治療のための表面関連抗原の同定

Country Status (6)

Country Link
US (4) US9090940B2 (https=)
EP (5) EP2311487A3 (https=)
JP (5) JP5253999B2 (https=)
DE (1) DE102005013846A1 (https=)
ES (1) ES2537319T3 (https=)
WO (1) WO2006100089A2 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005013846A1 (de) 2005-03-24 2006-10-05 Ganymed Pharmaceuticals Ag Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
DE102006060824B4 (de) * 2006-12-21 2011-06-01 Johannes-Gutenberg-Universität Mainz Nachweis von individuellen T-Zell-Reaktionsmustern gegen Tumor-assoziierte Antigene (TAA) in Tumorpatienten als Basis für die individuelle therapeutische Vakzinierung von Patienten
EP2060583A1 (en) * 2007-10-23 2009-05-20 Ganymed Pharmaceuticals AG Identification of tumor-associated markers for diagnosis and therapy
EP2249159A1 (en) * 2009-04-29 2010-11-10 Ganymed Pharmaceuticals AG Identification of tumor-associated markers for diagnosis and therapy
ES2729051T3 (es) 2009-07-29 2019-10-30 Kai Pharmaceuticals Inc Agentes terapéuticos para reducir los niveles de hormona paratiroidea
US8486657B2 (en) * 2010-03-22 2013-07-16 Xiaohong Cai Anti-preproprotein and anti-preprotein antibodies as immunohistochemical markers
TW201302800A (zh) * 2011-06-10 2013-01-16 腫瘤療法 科學股份有限公司 Ｓｅｍａ５ｂ胜肽及含其之疫苗
AU2013356143A1 (en) * 2012-12-04 2015-06-04 Oncotherapy Science, Inc. SEMA5B peptides and vaccines containing the same
CN106103711A (zh) 2013-11-21 2016-11-09 组库创世纪株式会社 T细胞受体和b细胞受体库分析系统及其在治疗和诊断中的应用
US11596652B2 (en) 2015-02-18 2023-03-07 Enlivex Therapeutics R&D Ltd Early apoptotic cells for use in treating sepsis
US11304976B2 (en) 2015-02-18 2022-04-19 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11497767B2 (en) 2015-02-18 2022-11-15 Enlivex Therapeutics R&D Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11000548B2 (en) 2015-02-18 2021-05-11 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
WO2016170541A1 (en) 2015-04-21 2016-10-27 Enlivex Therapeutics Ltd. Therapeutic pooled blood apoptotic cell preparations and uses thereof
US11318163B2 (en) 2015-02-18 2022-05-03 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11512289B2 (en) 2015-02-18 2022-11-29 Enlivex Therapeutics Rdo Ltd Combination immune therapy and cytokine control therapy for cancer treatment
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520564D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
RU2729116C2 (ru) 2015-12-16 2020-08-04 Гритстоун Онколоджи, Инк. Идентификация, производство и применение неоантигенов
WO2017123808A1 (en) 2016-01-15 2017-07-20 The J. David Gladstone Institutes Methods of treating disease by metabolic control of t-cell differentiation
CN109069539A (zh) 2016-02-18 2018-12-21 恩立夫克治疗有限责任公司 用于癌症治疗的联合免疫疗法和细胞因子控制疗法
CR20200059A (es) * 2017-07-07 2020-06-01 Immatics Biotechnologies Gmbh Nuevos péptidos y nuevas combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de pulmón, incluyendo el nsclc, el sclc y otros cánceres
KR20260039788A (ko) 2017-10-10 2026-03-20 시애틀 프로젝트 코포레이션 핫스팟을 이용한 신생항원 동정
CA3083097A1 (en) 2017-11-22 2019-05-31 Gritstone Oncology, Inc. Reducing junction epitope presentation for neoantigens
WO2022256620A1 (en) * 2021-06-03 2022-12-08 The Broad Institute, Inc. Novel targets for enhancing anti-tumor immunity

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2191A (en) 1841-07-23 Constructing the surgical instrument denominated the
GB9019812D0 (en) 1990-09-11 1990-10-24 Scotgen Ltd Novel antibodies for treatment and prevention of infection in animals and man
US5677139A (en) 1995-04-21 1997-10-14 President And Fellows Of Harvard College In vitro differentiation of CD34+ progenitor cells into T lymphocytes
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
ES2203782T3 (es) 1996-01-17 2004-04-16 Imperial College Innovations Limited Inmunoterapia que utiliza linfocitos t citotoxicos (ctl).
AU6337398A (en) * 1997-02-24 1998-09-09 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
WO1998055508A2 (en) * 1997-06-03 1998-12-10 Sagami Chemical Research Center HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
WO2000037491A2 (en) * 1998-12-22 2000-06-29 Genset Dnas encoding proteins with signal sequences
US20030204075A9 (en) * 1999-08-09 2003-10-30 The Snp Consortium Identification and mapping of single nucleotide polymorphisms in the human genome
WO2002012343A2 (en) * 2000-08-07 2002-02-14 Curagen Corporation Proteins and nucleic acids encoding g-protein coupled receptors
USH2191H1 (en) 2000-10-24 2007-06-05 Snp Consortium Identification and mapping of single nucleotide polymorphisms in the human genome
AU2002255478A1 (en) * 2001-01-10 2002-09-12 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
CA2444691A1 (en) * 2001-04-18 2002-10-31 Protein Design Labs, Inc. Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
JP2005500832A (ja) * 2001-06-18 2005-01-13 ロゼッタ・インファーマティクス・インコーポレーテッド 乳癌患者の診断および予後
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
US20040076955A1 (en) * 2001-07-03 2004-04-22 Eos Biotechnology, Inc. Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
DE10211088A1 (de) * 2002-03-13 2003-09-25 Ugur Sahin Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE10254601A1 (de) * 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
AU2003263660A1 (en) * 2003-08-29 2005-03-16 Pantarhei Bioscience B.V. Prenatal diagnosis of down syndrome by detection of fetal rna markers in maternal blood
DE10344799A1 (de) * 2003-09-26 2005-04-14 Ganymed Pharmaceuticals Ag Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
DE102005013846A1 (de) 2005-03-24 2006-10-05 Ganymed Pharmaceuticals Ag Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie

Similar Documents

Publication Publication Date Title
JP2008537546A5 (https=)
JP2007506417A5 (https=)
JP2007537197A5 (https=)
JP2010047597A5 (https=)
JP2006516190A5 (https=)
JP5498018B2 (ja) 胎盤成長因子（ＰｌＧＦ）媒介性の転移および／または血管新生の阻害
JP2008508861A5 (https=)
US9663584B2 (en) Antibodies to non-functional P2X7 receptor
JP6336696B2 (ja) がんおよび自己免疫疾患の診断および治療に使用するためのモノクローナル抗体
RU2008114318A (ru) Идентификация опухолевых антигенов для диагностики и терапии
JP2010063458A5 (https=)
JP6832887B2 (ja) 改変ａｘｌペプチド及び抗転移療法のａｘｌシグナル伝達阻害におけるその使用
JP7271446B2 (ja) Ｈｌａ－ｇ転写物およびアイソフォームおよびそれらの使用
JP2005519608A5 (https=)
CN114650842A (zh) 抗tim-3抗体
JP2007526759A5 (https=)
JP2008527998A (ja) Ｎｓｃｌｃの診断のためのｇｉｔｒ抗体
CN120137035A (zh) 一种抗犬pd-1抗体及其用途
JP2008509659A5 (https=)
CN101161283B (zh) CMTM1-v17的新应用及其拮抗剂
AU2002224901A1 (en) Method for diagnosing a tumor in a patient determining the concentration of PIBF
WO2002044734A1 (en) Method for diagnosing a tumor in a patient determining the concentration of pibf
CN121909040A (zh) 与β-连环蛋白相关的癌症的治疗
HK40126720A (zh) 一种抗犬pd-1抗体及其用途
CN119798408A (zh) 一种识别hpv多抗原表位的tcr及其编码序列